Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

TLIS | Talis Biomedical Corporation

Index- P/E- EPS (ttm)-47.92 Insider Own8.45% Shs Outstand1.82M Perf Week-3.28%
Market Cap10.80M Forward P/E- EPS next Y-23.32 Insider Trans0.00% Shs Float1.67M Perf Month-4.22%
Income-85.80M PEG- EPS next Q-7.37 Inst Own47.30% Short Float / Ratio0.84% / 1.07 Perf Quarter-18.06%
Sales2.90M P/S3.72 EPS this Y49.90% Inst Trans-72.81% Short Interest0.01M Perf Half Y-25.26%
Book/sh52.92 P/B0.11 EPS next Y27.60% ROA-55.40% Target Price5.00 Perf Year-50.96%
Cash/sh53.66 P/C0.11 EPS next 5Y47.30% ROE-70.70% 52W Range5.61 - 13.50 Perf YTD-11.75%
Dividend- P/FCF- EPS past 5Y- ROI-90.90% 52W High-56.29% Beta1.14
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin-26.10% 52W Low5.17% ATR0.45
Employees102 Current Ratio11.00 Sales Q/Q0.00% Oper. Margin- RSI (14)41.99 Volatility7.78% 6.46%
OptionableNo Debt/Eq0.00 EPS Q/Q45.60% Profit Margin- Rel Volume0.38 Prev Close5.63
ShortableYes LT Debt/Eq0.00 EarningsAug 10 AMC Payout- Avg Volume13.08K Price5.90
Recom5.00 SMA20-4.47% SMA50-14.97% SMA200-22.33% Volume4,945 Change4.80%
Date Action Analyst Rating Change Price Target Change
Jan-07-22Downgrade BofA Securities Neutral → Underperform $3
Sep-27-21Downgrade JP Morgan Neutral → Underweight $10 → $7
Aug-31-21Downgrade BTIG Research Buy → Neutral
Aug-12-21Downgrade Piper Sandler Overweight → Neutral $13 → $9
Aug-11-21Downgrade JP Morgan Overweight → Neutral $17 → $10
Mar-09-21Initiated Piper Sandler Overweight $17
Mar-09-21Initiated JP Morgan Overweight $18
Mar-09-21Initiated BTIG Research Buy $18
Mar-09-21Initiated BofA Securities Neutral $14
Aug-10-23 04:45PM
Aug-03-23 08:00AM
Aug-02-23 08:00AM
Jul-27-23 08:00AM
08:00AM Loading…
Jul-24-23 08:00AM
Jul-05-23 08:00AM
May-23-23 08:00AM
May-11-23 05:22PM
May-04-23 08:00AM
Mar-22-23 04:05PM
Nov-09-22 06:13AM
Nov-03-22 04:05PM
Aug-08-22 10:48AM
07:50AM Loading…
Aug-03-22 07:50AM
Aug-02-22 04:05PM
May-10-22 04:05PM
Apr-26-22 08:00AM
Apr-25-22 12:08PM
Apr-06-22 06:11PM
Mar-15-22 09:30PM
Mar-01-22 08:00AM
Feb-23-22 04:23AM
Feb-01-22 10:05AM
Dec-25-21 02:38AM
Dec-21-21 02:00PM
Dec-20-21 04:00PM
11:16AM Loading…
Dec-14-21 11:16AM
Dec-13-21 11:30PM
Dec-10-21 09:00AM
Dec-09-21 06:16PM
Dec-08-21 07:30PM
Dec-03-21 03:15PM
Dec-02-21 06:53PM
Nov-16-21 06:00AM
Nov-15-21 04:05PM
Nov-12-21 12:00PM
Nov-11-21 04:00PM
Nov-08-21 08:00AM
Oct-26-21 08:00AM
Oct-12-21 12:36PM
Sep-14-21 04:00PM
Sep-13-21 07:00PM
Sep-09-21 06:00PM
Sep-03-21 08:49AM
Aug-31-21 08:25PM
Aug-30-21 04:30PM
Aug-11-21 02:10PM
Aug-10-21 04:05PM
Jul-27-21 08:00AM
May-12-21 08:00AM
May-11-21 04:05PM
May-04-21 08:00AM
Apr-28-21 08:00AM
Mar-18-21 08:00AM
Mar-09-21 10:07AM
Mar-08-21 08:00AM
Feb-17-21 04:05PM
Feb-12-21 05:05PM
Feb-11-21 11:39PM
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also develops Talis One tests for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A and influenza B. The company was incorporated in 2013 and is headquartered in Redwood, California.